EPISODE · Oct 16, 2024 · 4 MIN
B+L Receives FDA Approval for enVista Envy IOL
from Eyewire News: The Podcast · host Eyewire News
Bausch + Lomb receives FDA approval for a new IOL on its enVista platform; Nanoscope advances it gene therapy for retinitis pigmentosa; and Orasis completes a major funding round to support the launch of its presbyopia eye drop. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
B+L Receives FDA Approval for enVista Envy IOL
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m